To identify the prime candidate miRNAs controlling the CD44 mRNA’s fate in glioma-derived tumor cell models and primary GBM, we analyzed the expression of miRNAs, which are predicted by TargetScan to target the CD44-3′UTR [34], by using small RNA-seq derived from cell models or publicly available data [35,36]. The gene discussed is CD44; the disease is glioma.